LEARRN: Techniques Development Component

学习:技术开发组件

基本信息

  • 批准号:
    10414904
  • 负责人:
  • 金额:
    $ 24.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY LeaRRN’s mission is to improve the quality, outcomes and value of rehabilitation care by fostering stakeholder- partnered research within and across Learning Health Systems (LHS). As part of the LeaRRN, the overarching objective of the Administrative Oversight Component is to catalyze and champion the mission, goals and activities of LeaRRN. This Component will be led by the experienced leadership team of Dr. Linda Resnik, PT, PhD, (PI), and Dr. Mary Slavin, PT, PhD (Investigator-BU). Their work will be guided by an Executive Committee (EC) and an independent national advisory board. The Administrative Oversight Component will provide scientific leadership and administrative oversight of all LeaRRN activities, identifying, coordinating and distributing resources, and facilitating communications and collaboration across all Components. The Administrative Oversight Component will evaluate and document the ongoing effectiveness of LeaRRN and fulfill all reporting requirements. This Component will also provide day-to-day administrative support, identifying and coordinating needed resources and distributing those resources back out to the Components. It will prioritize resource allocation and provide financial oversight, administering the budget and overseeing expenditures in a manner that maximizes shared resources. The Administrative Oversight Component, with input from the Executive Committee, will be responsible for evaluation of all LeaRRN programs and activities using a formal evaluation plan. LeaRRN’s Executive Committee will be chaired by Dr. Resnik. Members will include the Principal Investigators and Co-PIs of all other Components. The Administrative Oversight team will convene an Independent Advisory Board (IAB) to oversee the functioning of the Components and achievement of LeaRRN’s objectives. The IAB will provide guidance to insure that LeaRRN’s activities are responsive to the needs of the rehabilitation community. The successful achievement of the LeaRRN’s aims will be facilitated by its strong leadership team, and existing effective collaborations between investigators and institutions. LeaRRN’s Administrative Oversight Component will be based within the Brown University School of Public Health’s Center for Long-Term Care Quality & Innovation (Q&I Center). The Q&I Center is a component of the Center for Gerontology and HealthCare Research, a nationally-prominent health services research program that studies the diverse health and social service needs of older adults and those with chronic illnesses. The Administrative Oversight Component will be supported by a dedicated Program Manager, a Program Assistant based at Boston University, and the rich research administrative infrastructure of Brown University’s Center for Gerontology and Health Care Research.
项目摘要 LeaRRN的使命是通过培养利益相关者来提高康复护理的质量,结果和价值- 在学习健康系统(LHS)内部和跨学习健康系统(LHS)进行合作研究。作为LeaRRN的一部分, 行政监督部门的目标是促进和支持使命、目标和 LeaRRN的活动。该组件将由经验丰富的领导团队琳达Resnik博士,PT, 博士(PI)和玛丽斯拉文博士(PT,博士)(BU研究者)。他们的工作将由一名行政人员指导。 委员会(EC)和独立的国家咨询委员会。行政监督部门将 对所有LeaRRN活动提供科学领导和行政监督, 分配资源,并促进所有组件之间的通信和协作。的 行政监督部门将评价和记录LeaRRN的持续有效性, 满足所有报告要求。该构成部分还将提供日常行政支助, 以及协调所需的资源并将这些资源分配回组件。它将 确定资源分配的优先次序,提供财务监督,管理预算和监督 以最大化共享资源的方式支出。行政监督部门, 执行委员会的意见,将负责评估所有LeaRRN计划和活动 使用正式的评估计划。LeaRRN的执行委员会将由Resnik博士担任主席。成员将 包括所有其他组件的主要研究者和合作PI。行政监督小组将 成立一个独立咨询委员会(IAB),监督各组成部分的运作和成果 LeaRRN的目标。IAB将提供指导,以确保LeaRRN的活动响应 康复社区的需求。LeaRRN目标的成功实现将得到以下方面的促进: 其强大的领导团队,以及调查人员和机构之间现有的有效合作。 LeaRRN的行政监督部门将设在布朗大学公共学院 健康长期护理质量和创新中心(Q&I中心)Q&I中心是 老年学和医疗保健研究中心,一个全国著名的卫生服务研究计划 研究老年人和慢性病患者的各种健康和社会服务需求。的 行政监督部分将由一名专门的项目经理、一名项目助理 总部设在波士顿大学,布朗大学的中心, 老年学和保健研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LINDA J. RESNIK其他文献

LINDA J. RESNIK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LINDA J. RESNIK', 18)}}的其他基金

Advancing measurement of physical function in upper limb amputation
推进上肢截肢身体功能的测量
  • 批准号:
    10749083
  • 财政年份:
    2023
  • 资助金额:
    $ 24.45万
  • 项目类别:
LEARRN: Techniques Development Component
学习:技术开发组件
  • 批准号:
    10623285
  • 财政年份:
    2020
  • 资助金额:
    $ 24.45万
  • 项目类别:
LeaRRN: the Learning Health Systems Rehabilitation Research Network
LeaRRN:学习健康系统康复研究网络
  • 批准号:
    10163230
  • 财政年份:
    2020
  • 资助金额:
    $ 24.45万
  • 项目类别:
LeaRRN: the Learning Health Systems Rehabilitation Research Network
LeaRRN:学习健康系统康复研究网络
  • 批准号:
    10414898
  • 财政年份:
    2020
  • 资助金额:
    $ 24.45万
  • 项目类别:
LeaRRN: the Learning Health Systems Rehabilitation Research Network
LeaRRN:学习健康系统康复研究网络
  • 批准号:
    10623263
  • 财政年份:
    2020
  • 资助金额:
    $ 24.45万
  • 项目类别:
LEARRN: Collaboration Between Other Institutions Component
学习:其他机构之间的合作组件
  • 批准号:
    10623290
  • 财政年份:
    2020
  • 资助金额:
    $ 24.45万
  • 项目类别:
LEARRN: Collaboration Between Other Institutions Component
学习:其他机构之间的合作组件
  • 批准号:
    10414905
  • 财政年份:
    2020
  • 资助金额:
    $ 24.45万
  • 项目类别:
RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10165845
  • 财政年份:
    2019
  • 资助金额:
    $ 24.45万
  • 项目类别:
RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10454860
  • 财政年份:
    2019
  • 资助金额:
    $ 24.45万
  • 项目类别:
RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10621767
  • 财政年份:
    2019
  • 资助金额:
    $ 24.45万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
  • 批准号:
    MR/Y009681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
  • 批准号:
    MR/Y022947/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
  • 批准号:
    10068495
  • 财政年份:
    2024
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
  • 批准号:
    24K19850
  • 财政年份:
    2024
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
  • 批准号:
    491810
  • 财政年份:
    2023
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
  • 批准号:
    489316
  • 财政年份:
    2023
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Operating Grants
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
  • 批准号:
    23K14987
  • 财政年份:
    2023
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
  • 批准号:
    EP/Y027760/1
  • 财政年份:
    2023
  • 资助金额:
    $ 24.45万
  • 项目类别:
    Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
  • 批准号:
    10733789
  • 财政年份:
    2023
  • 资助金额:
    $ 24.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了